Bellerophon Therapeutics Stock (OTC: BLPH) stock price, news, charts, stock research, profile.
|Vol / Avg.39.520K / 368.190K||Mkt Cap440.375K|
|Day Range0.032 - 0.038||52 Wk Range0.029 - 12.580|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-06-06||HC Wainwright & Co.||Andrew Fein||Maintains||BuyBuy||Lowers||30.00||2.00|
|2023-06-06||Laidlaw & Co.||Yale Jen||Downgrades||BuyHold||-||-||-|
|2023-05-17||HC Wainwright & Co.||Andrew Fein||Reinstates||BuyBuy||Maintains||-||30.00|
|2023-05-09||Laidlaw & Co.||Yale Jen||Initiates Coverage On||Buy||Announces||-||35.00|
You can purchase shares of Bellerophon Therapeutics (OTCPK: BLPH) through any online brokerage.
There are no as such competitors for Bellerophon Therapeutics.
The latest price target for Bellerophon Therapeutics (OTCPK: BLPH) was reported by HC Wainwright & Co. on Tuesday, June 6, 2023. The analyst firm set a price target for 2.00 expecting BLPH to rise to within 12 months (a possible 5960.61% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Bellerophon Therapeutics (OTCPK: BLPH) is $0.033 last updated Today at December 7, 2023 at 7:27 PM UTC.
There is no dividend information for Bellerophon Therapeutics.
Bellerophon Therapeutics’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Bellerophon Therapeutics.
Bellerophon Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.